Japan Blood Products Organization
CompanyJapanFounded 2012
Japan Blood Products Organization develops one asset, in phase 3 (Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified in chronic inflammatory demyelinating polyneuropathy). Mostly plasma or blood product; based in Japan, founded in 2012.
- 1
- Asset
- Furthest stage
- Phase 3
- 3
- Trials
- 15
- Signals
Pipeline
1Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified
Replaces deficient immunoglobulin G to provide passive immunity against infections.
Phase 3, Plasma or blood product, chronic inflammatory demyelinating polyneuropathy, dermatomyositis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials3
- Signals20
- Similar companies6